Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-10-10 / Stem Cell Res Ther 2016 10;7(1):149https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-10-10 / Stem Cell Res Ther 2016 10;7(1):1492016-10-10 00:00:002019-02-15 09:00:20Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-10-04 / Oncotarget 2016 Oct;7(40):65042-65051https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-10-04 / Oncotarget 2016 Oct;7(40):65042-650512016-10-04 00:00:002016-10-04 00:00:00Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-09-29 / Cancer Immunol. Immunother. 2016 12;65(12):1499-1509https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-09-29 / Cancer Immunol. Immunother. 2016 12;65(12):1499-15092016-09-29 00:00:002019-02-15 08:47:26Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):64https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):642016-08-24 00:00:002019-02-15 08:39:07A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-08-14 / Int J Hyperthermia 2016 11;32(7):809-21https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-08-14 / Int J Hyperthermia 2016 11;32(7):809-212016-08-14 00:00:002019-02-15 08:35:47Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-08-12 / Int J Hyperthermia 2016 11;32(7):801-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-08-12 / Int J Hyperthermia 2016 11;32(7):801-82016-08-12 00:00:002019-02-15 08:35:46A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2016-08-10 12:33:022020-05-27 11:26:48Artikel von Prof Schirrmacher in Biomedicines: „Fifty Years of Clinical Application of Newcastle Disease Virus“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-07-22 / Cancer Immunol. Immunother. 2016 09;65(9):1099-111https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-07-22 / Cancer Immunol. Immunother. 2016 09;65(9):1099-1112016-07-22 00:00:002019-02-15 08:45:42Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-07-21 / Onco Targets Ther 2016;9:4441-51https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-07-21 / Onco Targets Ther 2016;9:4441-512016-07-21 00:00:002023-03-07 11:15:56Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-07-19 / Clin. Cancer Res. 2017 Jan;23(2):399-406https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-07-19 / Clin. Cancer Res. 2017 Jan;23(2):399-4062016-07-19 00:00:002019-02-15 08:39:09PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-07-18 / Case Rep Med 2016;2016:9639585https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-07-18 / Case Rep Med 2016;2016:96395852016-07-18 00:00:002019-02-15 08:49:45Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002016-07-12 / Cytotherapy 2016 09;18(9):1178-86https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2016-07-12 / Cytotherapy 2016 09;18(9):1178-862016-07-12 00:00:002020-06-23 10:01:20Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy
Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
Induction of Immune Response after Allogeneic Wilms‘ Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
Local hyperthermia in head and neck cancer: mechanism, application and advance
A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses
A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
Article by Prof. Schirrmacher in Biomedicines: "Fifty Years of Clinical Application of Newcastle Disease Virus"
Advances and challenges: dendritic cell vaccination strategies for glioblastoma
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma
Immunotherapy for the Treatment of Urothelial Carcinoma
Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer
Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
PD-1 blockade enhances the vaccination-induced immune response in glioma
A Perspective of Immunotherapy for Prostate Cancer
Immunological Aspects of Malignant Gliomas